Hologic (HOLX) Announces Favorable Ruling in SenoRx Patent Infringement Suit
Hologic (Nasdaq: HOLX) shares are trading just off session highs as the company announced a favorable ruling in its patent infringement suit related to SenoRx.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merrill Lynch Will Pay $415M to Settle SEC Investigation (BAC)
- Volatility indexes prices
- Stocks with Implied Volatility Movement